Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Details)

v3.20.1
SEGMENT INFORMATION (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
segment
Dec. 31, 2018
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 2  
Product sales, net $ 53,696 $ 48,244
Gross profit 35,088 33,878
Research and development 5,877 1,885
Selling, general and administrative 46,451 21,746
Operating income (loss) (17,240) 10,247
Goodwill 2,788 2,788
Consumer Products    
Segment Reporting Information [Line Items]    
Product sales, net 53,696 48,244
Gross profit 35,088 33,878
Research and development 2,106 1,008
Selling, general and administrative 46,405 21,697
Operating income (loss) (13,423) 11,173
Specialty Pharmaceuticals    
Segment Reporting Information [Line Items]    
Product sales, net 0 0
Gross profit 0 0
Research and development 3,771 877
Selling, general and administrative 46 49
Operating income (loss) (3,817) (926)
Goodwill 2,800 2,800
Intangible assets $ 3,800 $ 3,800